Financials data is unavailable for this security.
View more
Year on year Candel Therapeutics Inc 's revenues fell -100.00% from 125.00k to 0.00. has fallen 101.87% from a loss of 18.79m to a larger loss of 37.94m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -117.35% |
---|---|
Return on equity | -480.68% |
Return on investment | -158.61% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Candel Therapeutics Inc fell by 34.65m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 34.24m for operations while cash used for investing totalled 280.00k.
Cash flow per share | -1.68 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.321 |
---|---|
Tangible book value per share | -0.321 |
More ▼
Balance sheet in USDView more
Current ratio | 1.62 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 2.36 |
More ▼